Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Mar 1.

Published in final edited form as: Diagn Cytopathol. 2019 Dec 6;48(3):183–190. doi: 10.1002/dc.24350

TABLE 2.

Benign salivary gland neoplasms

	Milan category
	I	II	III	IVa	IVb	V	VI
Pleomorphic adenoma (n = 99)	7.1% (7/99)	2% (2/99)	0	73.7% (73/99)	17.2% (17/99)	0	0
Warthin tumor (n = 26)	3.8% (1/26)	19.2% (5/26)	7.7% (2/26)	53.8% (14/26)	15.4% (4/26)	0	0
Oncocytoma (n = 13)	7.7% (1/13)	0	7.7% (1/13)	7.7% (1/13)	76.9% (10/13)	0	0
Intercalated duct adenoma (n = 2)	0	50% (1/2)	0	0	50% (1/2)	0	0
Basal cell adenoma (n = 2)	0	0	0	0	100% (2/2)	0	0
Intercalated duct adenoma (n = 2)	0	50% (1/2)	0	0	50% (1/2)	0	0
Cystadenoma (n = 1)	0	0	100% (1/1)	0	0	0	0
Total (n = 144)	6.3% (9/144)	6.3% (9/144)	2.8% (4/144)	61.1% (88/144)	24.3% (35/144)	0	0